Subretinal Photovoltaic Implant to Restore Vision in Geographic Atrophy Due to AMD

LensesMacular Diseases

Exudative AMD Risk Following Blue Light-Filtering IOL Implantation: A Population-Based Study According to Non-Exudative AMD Status

Am J Ophthalmol

Kim JY, Kim S, Cho J, Lee JS, Lee CS, Byeon SH, Kim SS, Lee SW, Kim YJ

doi: 10.1016/j.ajo.2025.07.007

Further Publications

Patient-Reported Importance of Functional Benefit in Geographic Atrophy

JAMA Ophthalmol

Dinah C, Enoch J, Ghulakhszian A, Sekhon M, Salvatore S, DeSalvo G, Kumar P, Banerjee S, Nayak D, Amoaku W, Shiew M, Osoba O, Crabb DP, Taylor DJ

doi: 10.1001/jamaophthalmol.2025.3264

Macular Diseases

Real-World Experience with Intravitreal Pegcetacoplan for the Treatment of Geographic Atrophy in Age-Related Macular Degeneration

Am J Ophthalmol

Shen M, Berni A, Liu J, Hiya F, Herrera G, El-Mulki OS, Beqiri S, Cheng Y, Kastner J, Trivizki O, Kumar S, Zhang Y, Le VH, O'Brien RC, Nicola MD, Yehoshua Z, Dubovy SR, Wang RK, Gregori G, Rosenfeld PJ

doi: 10.1016/j.ajo.2025.09.006

Macular DiseasesFurther Publications

Progression of Loss of Vision From Centre-Involving Macular Atrophy in Eyes Treated for nAMD

Clin Exp Ophthalmol

Teo KYC, Ponsioen TL, Lan S, OToole L, Arruabarrena Sanchez C, Barry R, Morros HB, Chung C, Invernizzi A, Cheung GCM, Barthelmes D, Gillies MC

doi: 10.1111/ceo.14587

Macular Diseases

Long-Term Natural History of Treatment-Naïve Geographic Atrophy in Age-Related Macular Degeneration

Transl Vis Sci Technol

Muth DR, Quérat L, Venkataraman AP, Dominguez-Vicent A, Petrovski G, Williams PA, Locri F, Zweifel SA, Kvanta A

doi: 10.1167/tvst.14.5.5

Further Publications

Geographic Atrophy Multifocality in the Age-Related Eye Disease Study 2

JAMA Ophthalmol

von der Emde L, Hou J, Mukherjee S, Vance E, Agrón E, Domalpally A, Keenan TDL, AREDS2 Research Group

doi: 10.1001/jamaophthalmol.2025.3979

Further Publications

Evaluating the Progression of Retinal Sensitivity Loss in Geographic Atrophy Using Machine-Learning-Based Structure-Function Correlation (OMEGA 2)

Invest Ophthalmol Vis Sci

Ansari G, Schärer N, Pfau K, Valmaggia P, Gabrani C, Zuche H, Giani A, Esmaeelpour M, Yamaguchi TC, Feltgen N, Maloca PM, Schmetterer L, Scholl HPN, Pfau M

doi: 10.1167/iovs.66.11.34

Retinal Diseases

Three-Year Clinical Outcomes in Geographic Atrophy: An Analysis of 18,712 Patient Eyes

Retina

Shughoury A, Boucher N, Aggarwal N, Ciulla TA

doi: 10.1097/IAE.0000000000004285

Macular DiseasesRetinal Diseases

Ocular Adverse Events Associated with Pegcetacoplan and Avacincaptad Pegol for Geographic Atrophy: A Population-Based Pharmacovigilance Study: Ocular Adverse Events of Pegcetacoplan & Avacincaptad Pegol

Am J Ophthalmol

Kailani Z, Mihalache A, Popovic MM, Kertes PJ, Muni RH

doi: 10.1016/j.ajo.2025.04.022

Related content

Exudative AMD Risk Following Blue Light-Filtering IOL Implantation: A Population-Based Study According to Non-Exudative AMD Status

Patient-Reported Importance of Functional Benefit in Geographic Atrophy

Real-World Experience with Intravitreal Pegcetacoplan for the Treatment of Geographic Atrophy in Age-Related Macular Degeneration

Progression of Loss of Vision From Centre-Involving Macular Atrophy in Eyes Treated for nAMD

Long-Term Natural History of Treatment-Naïve Geographic Atrophy in Age-Related Macular Degeneration

Geographic Atrophy Multifocality in the Age-Related Eye Disease Study 2

Evaluating the Progression of Retinal Sensitivity Loss in Geographic Atrophy Using Machine-Learning-Based Structure-Function Correlation (OMEGA 2)

Three-Year Clinical Outcomes in Geographic Atrophy: An Analysis of 18,712 Patient Eyes

Ocular Adverse Events Associated with Pegcetacoplan and Avacincaptad Pegol for Geographic Atrophy: A Population-Based Pharmacovigilance Study: Ocular Adverse Events of Pegcetacoplan & Avacincaptad Pegol